Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS)

Status Terminated

Clinical Trial Summary

The purpose of this study is to determine if transurethral photodynamic therapy with lemuteporfin has a therapeutic effect on lower urinary tract symptoms due to an enlarged prostate.

Photodynamic therapy (known as "PDT") is a treatment that uses light to make a drug work. This means the drug is "light-activated". Light-activated drugs do not work until a certain color of light shines on the drug. When the drug and the light combine, they react together to destroy tissue.

This study is investigating PDT with lemuteporfin as a possible treatment for an enlarged prostate. PDT with lemuteporfin may destroy overgrown prostate tissue and help urinary symptoms go back to normal.

Clinical Trial Description

This is a multi-center, randomized, sham-controlled, double-blind, dose-finding study in parallel groups of subjects with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). All subjects will receive a fixed dose of lemuteporfin injected transurethrally into the prostate followed by transurethral application of either one of three active light doses or a sham light dose. Subjects will be followed for safety and efficacy for a minimum of three months to a maximum of 12 months. The primary study endpoint will be the change from baseline in AUA SI score at three months. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00116571
Study type	Interventional
Source	QLT Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	May 2005
Completion date	December 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02578953` - Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects	Phase 1
Terminated	`NCT02396420` - Prostate Artery Embolization as a Treatment for Benign Prostatic Hyperplasia in Men With Prostates Larger Than 90 Grams	Phase 2
Terminated	`NCT04398966` - Prostatic Artery Embolization vs Medication for Benign Prostatic Hyperplasia	N/A
Not yet recruiting	`NCT06452927` - EEP in Patients With Urodynamically Proven DU/DA	N/A
Completed	`NCT02947958` - Teleconsultation in Counter-reference Between Tertiary and Primary Care for Patients With Benign Prostatic Hyperplasia	N/A
Completed	`NCT01937871` - A Study of Tadalafil in Men With Benign Prostatic Hyperplasia (BPH) and Erectile Dysfunction (ED)	Phase 3
Completed	`NCT00427882` - Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study	Phase 4
Completed	`NCT02244320` - Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)	N/A
Completed	`NCT01254071` - A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry.	Phase 1
Recruiting	`NCT04108871` - Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men	N/A
Recruiting	`NCT05686525` - Clinical Trial on the Effectiveness of TUMT Compared to PAE in Reducing Severe LUTS in Men With BPH	N/A
Completed	`NCT01957189` - This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples	Phase 1
Completed	`NCT00316732` - Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS	N/A
Completed	`NCT02715401` - PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers	Phase 1
Recruiting	`NCT02278679` - Digital Rectal Exam Proficiency Tool	N/A
Completed	`NCT01376258` - Benefits of Adherence to 5-alpha Reductase Inhibitor Treatment in Men With Enlarged Prostate: An Assessment of Medicare and Medicaid Patients Using the MarketScan Database	N/A
Completed	`NCT01482676` - The Role of microRNAs in Organ Remodeling in Lower Urinary Tract Dysfunction	N/A
Completed	`NCT00822952` - Prostate Mechanical Imager (PMI) Clinical Bridging Study	N/A
Completed	`NCT00527605` - Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH)	Phase 3
Terminated	`NCT00563485` - Randomized Trial Comparing Terazosin 5 mg Daily and Doxazosin GITS 4 mg Daily for Trial Without Catheter in Acute Urinary Retention With Long Term Follow up	N/A